Literature DB >> 1713604

Characterization of a new minor lymphocyte stimulatory system. I. Cluster of self antigens recognized by "I-E-reactive" V beta s, V beta 5, V beta 11, and V beta 12 T cell receptors for antigen.

R Abe1, O Kanagawa, M A Sheard, B Malissen, M Foo-Phillips.   

Abstract

In the mouse, two sets of V beta gene products have been shown to be associated with T cell recognition of endogenous self Ag. One of these is the set of V beta associated with T cell reactivities to stimulatory Mls gene products, Mlsa (V beta 6, V beta 8.1, V beta 9) or Mlsc (V beta 3); another is the set of V beta, such as V beta 5, V beta 11, V beta 12, or V beta 17a, which were originally found to be related to I-E recognition. Although the Mls system has been well characterized, little is known about the nature of the ligands for the second set of V beta. In this work, we describe the evidence that the natural ligand or ligands of V beta 5, V beta 11, and V beta 12 may be novel Mls determinants that are recognized by naive T cells at a high precursor frequency and function as the ligand for clonal deletion of self-reactive T cells by negative selection. However, surprisingly, unlike the conventional Mls system, in which all V beta associated with Mlsa recognition or Mlsc recognition are uniformly deleted in those animals expressing the relevant Mls type, expression of these three V beta segregates independently among strains. Based on these observations, the nature of T cell recognition for this new Mls gene product(s) is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713604

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors.

Authors:  Johannes L Zakrzewski; David Suh; John C Markley; Odette M Smith; Christopher King; Gabrielle L Goldberg; Robert Jenq; Amanda M Holland; Jeremy Grubin; Javier Cabrera-Perez; Renier J Brentjens; Sydney X Lu; Gabrielle Rizzuto; Derek B Sant'Angelo; Isabelle Riviere; Michel Sadelain; Glenn Heller; Juan Carlos Zúñiga-Pflücker; Chen Lu; Marcel R M van den Brink
Journal:  Nat Biotechnol       Date:  2008-03-30       Impact factor: 54.908

2.  T-cell receptor b-V repertoire expression in the absence of an endogenous mouse mammary tumor provirus.

Authors:  R J Hodes; R Abe; D Gallahan; R Callahan
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

3.  Expression of mouse mammary tumor virus superantigen mRNA in the thymus correlates with kinetics of self-reactive T-cell loss.

Authors:  A Barnett; F Mustafa; T J Wrona; M Lozano; J P Dudley
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

4.  Mouse xenoantigens contribute to rat T-cell Vbeta repertoire generation in mixed xenogeneic bone marrow chimeras.

Authors:  Y Huang; S T Ildstad; M Neipp; H Shirwan
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

5.  A comparative study of T-cell receptor V beta usage in non-obese diabetic (NOD) and I-E transgenic NOD mice.

Authors:  N M Parish; H Acha-Orbea; E Simpson; S X Qin; T Lund; A Cooke
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

6.  T-cell repertoire in a strain of transgenic C57BL/6 mice with the HLA-DRA gene on the X-chromosome.

Authors:  Y Fukui; Y Esaki; A Kimura; K Hirokawa; Y Nishimura; T Sasazuki
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

7.  Cross-species transplantation tolerance: rat bone marrow-derived cells can contribute to the ligand for negative selection of mouse T cell receptor V beta in chimeras tolerant to xenogeneic antigens (mouse + rat----mouse).

Authors:  S T Ildstad; M S Vacchio; P M Markus; M L Hronakes; S M Wren; R J Hodes
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.